Skip to content

eSET Plus Single Embryo Cryotransfer vs Double Embryo Transfer

Randomized Clinical Trial Comparing Elective Single Embryo Transfer Plus Single Embryo Cryotransfer vs Double Embryo Transfer

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01909570
Acronym
eSET
Enrollment
194
Registered
2013-07-26
Start date
2010-01-31
Completion date
2013-12-31
Last updated
2024-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility, Pregnancy, Multiple

Brief summary

The purpose of this study is to determine whether a policy of elective single embryo transfer (eSET) plus single embryo cryotransfer is as effective as a double embryo transfer in terms of clinical pregnancy rate

Detailed description

The objective is to evaluate the In Vitro Fertilization/Intracytoplasmic Sperm Inyection (IVF/ICSI) results in terms of clinical pregnancy and multiple pregnancy rates, comparing elective single embryo transfer plus cryotransfer of one embryo if pregnancy is not achieved, with double embryo transfer. This is a prospective randomized study, including couples arriving to the Reproductive Unit of the Hospital Universitario Virgen de las Nieves. All these patients had good reproductive prognosis and had been asigned randomly to one of the following groups: Group 1: elective single embryo transfer. In the case pregnancy is not achieved a cryotransfer of one embryo will be carried out. Group 2: elective double embryo transfer.

Interventions

PROCEDUREElective single embryo transfer

After the FIV/ICSI procedure, the embryo transfer in this arm would be of one embryo followed by the cryotransfer of one embryo in case of no conception in the fresh cycle.

After the FIV/ICSI procedure, the embryo transfer in this arm would be of two fresh embryos

Sponsors

Instituto de Salud Carlos III
CollaboratorOTHER_GOV
University Hospital Virgen de las Nieves
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 37 Years
Healthy volunteers
No

Inclusion criteria

* women less tan 38 years * women Body Mass Index (BMI) between 19-39 kg/m2 * Follicle-Stimulating Hormone (FSH) \<15 mUI/mL on cycle third day * First IVF/ICSI cycle or second after a positive pregnancy test in the first one

Exclusion criteria

* More tan five years of infertility * Previous uterus surgery * Uterus malformations * More tan one miscarriage

Design outcomes

Primary

MeasureTime frameDescription
Clinical Pregnancy RateSeven weeks after embryo transferA clinical pregnancy was defined by the presence of a gestational sac with heartbeat on transvaginal ultrasonography at the 7th weeks of pregnancy

Secondary

MeasureTime frameDescription
Multiple Pregnancy RateSeven weeks after embryo transferA multiple clinical pregnancy was defined by the presence of more than one gestational sac with heartbeat on transvaginal ultrasonography at the 7th weeks of pregnancy

Other

MeasureTime frameDescription
Live Birth Delivery Rate38 weeks after embryo transferThe delivery of a healthy child (o two)

Countries

Spain

Participant flow

Recruitment details

The recruitment period was from January 2010 to December 2012. The location of the recruitment was University Hospital of Virgen de las Nieves in Granada.

Pre-assignment details

A total of 194 women aged under 38 years were included in the study. Of these, 19 women were not randomised. The reasons were refusion to participate (n= 6), economic reasons (n = 2), participating in another study (n= 7) and not meeting criteria in further evaluation (n = 4).

Participants by arm

ArmCount
Elective Single Embryo Transfer
Elective single embryo transfer plus single embryo cryotransfer in case of no fresh conception
84
Double Embryo Transfer
Transfer of two fresh embryos
91
Total175

Baseline characteristics

CharacteristicElective Single Embryo TransferTotalDouble Embryo Transfer
Age, Continuous32.2 years
STANDARD_DEVIATION 3.6
32.0 years
STANDARD_DEVIATION 3.7
31.7 years
STANDARD_DEVIATION 3.8
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
84 Participants175 Participants91 Participants
Region of Enrollment
Spain
84 participants175 participants91 participants
Sex: Female, Male
Female
84 Participants175 Participants91 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
3 / 845 / 91
serious
Total, serious adverse events
0 / 840 / 91

Outcome results

Primary

Clinical Pregnancy Rate

A clinical pregnancy was defined by the presence of a gestational sac with heartbeat on transvaginal ultrasonography at the 7th weeks of pregnancy

Time frame: Seven weeks after embryo transfer

Population: Women aged under 38 years, with BMI between 19-29 kg/m2, FSH \<15mUI/mL on the third day and first cycle of IVF/ICSI or second cycle after a prior attempt with a positive pregnancy test result. The infertile period must be less of five years, without previous uterine surgery, uterine malformations, neither repeated spontaneous abortions.

ArmMeasureValue (NUMBER)
Elective Single Embryo TransferClinical Pregnancy Rate44.0 percentage of pregnancy per transfer
Double Embryo TransferClinical Pregnancy Rate37.4 percentage of pregnancy per transfer
Secondary

Multiple Pregnancy Rate

A multiple clinical pregnancy was defined by the presence of more than one gestational sac with heartbeat on transvaginal ultrasonography at the 7th weeks of pregnancy

Time frame: Seven weeks after embryo transfer

Population: Women aged under 38 years, with BMI between 19-29 kg/m2, FSH \<15mUI/mL on the third day and first cycle of IVF/ICSI or second cycle after a prior attempt with a positive pregnancy test result. The infertile period must be less of five years, without previous uterine surgery, uterine malformations, neither repeated spontaneous abortions.

ArmMeasureValue (NUMBER)
Elective Single Embryo TransferMultiple Pregnancy Rate0 percentage of multiple pregnancies
Double Embryo TransferMultiple Pregnancy Rate26.4 percentage of multiple pregnancies
Other Pre-specified

Live Birth Delivery Rate

The delivery of a healthy child (o two)

Time frame: 38 weeks after embryo transfer

Population: Women aged under 38 years, with BMI between 19-29 kg/m2, FSH \<15mUI/mL on the third day and first cycle of IVF/ICSI or second cycle after a prior attempt with a positive pregnancy test result. The infertile period must be less of five years, without previous uterine surgery, uterine malformations, neither repeated spontaneous abortions.

ArmMeasureValue (NUMBER)
Elective Single Embryo TransferLive Birth Delivery Rate45.2 percentage of live birth
Double Embryo TransferLive Birth Delivery Rate41.8 percentage of live birth

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026